Study of Oral Zileuton in the Treatment of Moderate to Severe Facial Acne Vulgaris
NCT00098358
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
90
Enrollment
INDUSTRY
Sponsor class
Conditions
Acne Vulgaris
Interventions
DRUG:
Zileuton
Sponsor
Critical Therapeutics